Stock Events

Stock Events

Sunshine Biopharma 

$0.049900
68
+$0.02+60.97% 15:54 Today

Statistics

Day High
0.0499
Day Low
0.0499
52W High
0.0499
52W Low
0.0499
Volume
100
Avg. Volume
-
Mkt Cap
118,678.02
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10NovExpected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
Next
-535
-356.7
-178.41
-0.11
Expected EPS
-0.2
Actual EPS
N/A

Financials

-16.46%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
36.31MRevenue
-5.98MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SBFMW. It's not an investment recommendation.
NVIDIA
8
NVDA
AMD
8
AMD
Tesla
6
TSLA
Amazon
6
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap335.14B
Merck & Co., Inc. is a global healthcare company that develops medications and vaccines across various areas, including oncology, directly competing with Sunshine Biopharma's focus on cancer treatment.
Pfizer
PFE
Mkt Cap152.69B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products including medicines and vaccines for oncology, competing in the same space as Sunshine Biopharma.
Bristol-Myers Squibb
BMY
Mkt Cap130.39B
Bristol-Myers Squibb Company specializes in biopharmaceuticals, including cancer treatments, making it a direct competitor in the oncology sector.
Gilead Sciences
GILD
Mkt Cap171.56B
Gilead Sciences, Inc. focuses on the discovery, development, and commercialization of innovative medicines in areas of unmet medical need, including oncology, competing with Sunshine Biopharma's research and products.
AMGEN
AMGN
Mkt Cap224.63B
Amgen Inc. is a biotechnology company that develops innovative human therapeutics, with a strong focus on oncology treatments, competing in the same field as Sunshine Biopharma.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie Inc. is a research-based biopharmaceutical company that develops and markets advanced therapies, including in oncology, making it a competitor.
Novartis
NVS
Mkt Cap286.78B
Novartis AG is a global healthcare company that provides solutions to address the evolving needs of patients worldwide, including in oncology, competing with Sunshine Biopharma.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses worldwide, with a significant focus on oncology, making it a competitor.
Astrazeneca
AZN
Mkt Cap242.64B
AstraZeneca PLC is a biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines, including for cancer, competing with Sunshine Biopharma.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson is a diversified healthcare company that develops and sells pharmaceuticals and medical devices, including cancer treatments, making it a competitor in the oncology market.

About

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
Show more...
CEO
Steve N. Slilaty
Employees
50
Country
United States
ISIN
US8677815024

Listings

XNAS
US
SBFM
BOATS
BOATS
SBFM.BOATS
XNAS
US
SBFMW

0 Comments

Share your thoughts

FAQ

What is Sunshine Biopharma stock price today?▼
The current price of SBFMW is $0.05 USD — it has increased by +60.97% in the past 24 hours. Watch Sunshine Biopharma stock price performance more closely on the chart.
What is Sunshine Biopharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Sunshine Biopharma stocks are traded under the ticker SBFMW.
What is Sunshine Biopharma market cap?▼
Today Sunshine Biopharma has the market capitalization of 118,678.02
When is the next Sunshine Biopharma earnings date?▼
Sunshine Biopharma is going to release the next earnings report on November 10, 2026.
What is Sunshine Biopharma revenue for the last year?▼
Sunshine Biopharma revenue for the last year amounts to 36.31M USD.
What is Sunshine Biopharma net income for the last year?▼
SBFMW net income for the last year is -5.98M USD.
How many employees does Sunshine Biopharma have?▼
As of August 19, 2026, the company has 50 employees.
In which sector is Sunshine Biopharma located?▼
Sunshine Biopharma operates in the Health & Wellness sector.
When did Sunshine Biopharma complete a stock split?▼
The last stock split for Sunshine Biopharma was on August 08, 2024 with a ratio of 1:20.
Where is Sunshine Biopharma headquartered?▼
Sunshine Biopharma is headquartered in FORT LAUDERDALE, United States.